{"id":150967,"date":"2022-11-24T02:27:22","date_gmt":"2022-11-24T08:27:22","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2022\/11\/extending-anti-clotting-treatment-after-distal-deep-vein-thrombosis-could-reduce-further-clot-risk"},"modified":"2022-11-24T02:27:22","modified_gmt":"2022-11-24T08:27:22","slug":"extending-anti-clotting-treatment-after-distal-deep-vein-thrombosis-could-reduce-further-clot-risk","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2022\/11\/extending-anti-clotting-treatment-after-distal-deep-vein-thrombosis-could-reduce-further-clot-risk","title":{"rendered":"Extending anti-clotting treatment after distal deep vein thrombosis could reduce further clot risk"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/extending-anti-clotting-treatment-after-distal-deep-vein-thrombosis-could-reduce-further-clot-risk2.jpg\"><\/a><\/p>\n<p>Giving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of further clots developing up to two years after treatment, finds a trial published by <i>The BMJ<\/i> today.<\/p>\n<p>What\u2019s more, the additional six weeks of treatment did not result in increased bleeding risk, a common side effect of anti-clotting drugs.<\/p>\n<p>Rivaroxaban is an anticoagulant drug. It\u2019s given to people at a high risk of getting <a href=\"https:\/\/medicalxpress.com\/tags\/dangerous+blood+clots\/\" rel=\"tag\" class=\"\">dangerous blood clots<\/a> to help their blood <a href=\"https:\/\/medicalxpress.com\/tags\/clot\/\" rel=\"tag\" class=\"\">clot<\/a> (thicken) more slowly.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Giving the anti-clotting drug rivaroxaban to patients for 12 weeks instead of the usual six after a blood clot in the lower leg reduces the risk of further clots developing up to two years after treatment, finds a trial published by The BMJ today. What\u2019s more, the additional six weeks of treatment did not result [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-150967","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/150967","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=150967"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/150967\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=150967"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=150967"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=150967"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}